When was Life Science Venture Capital founded?

Life Science Venture Capital was founded in 2000.

Where is Life Science Venture Capital headquartered?

Life Science Venture Capital is headquartered in Tokyo, Japan.

How many investments has Life Science Venture Capital made?

Life Science Venture Capital has made 24 investments.

What has Life Science Venture Capital invested in?

Life Science Venture Capital has made numerous investments in companies like Two Cells , J-Pharma , and Shattuck Labs within the Drug Discovery and Biotechnology industries.

What has Life Science Venture Capital invested in recently?

Life Science Venture Capital's latest investment was on 26-Nov-2021 in Two Cells , a company within the Drug Discovery industry.

Life Science Venture Capital Investor Profile: Portfolio & Exits

Life Science Venture Capital Overview

Investor Type

Venture Capital

Status

Inactive

Investments

24

Exits

24

Life Science Venture Capital General Information

Company Description

Founded in 2000, Life Science Venture Capital was a corporate venture arm of Medical & Biological Laboratories Company based in Tokyo, Japan. The firm sought to invest in the biotechnology and life science sectors.

Business Details

Website

mblvc.co.jp

Formerly Known As

MBL Venture Capital Co., Ltd., MBL, MBL Venture Capital

Year Founded

2000

Investor Status

Out of Business

Primary Investor Type

Corporate Venture Capital

Other Investor Types

Venture Capital

Corporate Office

1-2-2 Kanda, Chiyoda-ku
Ogawa Building 2F
Tokyo
Japan

Life Science Venture Capital Investments (24)

Company Name	Deal Date	Deal Type	Deal Size	Industry	Company Stage
Two Cells	26-Nov-2021	Later Stage VC	000.00	Drug Discovery	Clinical Trials - Phase 3
J-Pharma	11-Aug-2021	00000 00000	000.00	Drug Discovery	Clinical Trials - Phase 3
Shattuck Labs	12-Jun-2020	00000 00000	00000	Biotechnology	Generating Revenue/Not Profitable
CellGenTech	29-May-2019	00000 00000	00.000	Drug Discovery	Generating Revenue
Momotaro Gene	15-Mar-2019	00000 00000	00.000	Drug Discovery	Generating Revenue
Second Genome	15-Mar-2019	00000 00000	0000	Drug Discovery	Clinical Trials - Phase 2
KORTUC	10-Jan-2019	00000 00000	00000	Biotechnology	Clinical Trials - Phase 2
Sentien	28-Sep-2018	00000 00000	0000	Biotechnology	Clinical Trials - Phase 2
Himuka AM Pharma	19-Jun-2018	Early Stage VC	00.000	Drug Discovery	Clinical Trials - Phase 1
Thermalin	12-Jun-2018	Later Stage VC	0000	Drug Discovery	Out of Business

You’re viewing 10 of 24 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Life Science Venture Capital Exits (24)

Company Name	Exit Date	Exit Type	Exit Size
Sentien	15-Mar-2023	Secondary Transaction - Private
Himuka AM Pharma	01-Mar-2023	000000000 00
IDAC Theranostics	01-Mar-2023	000000000 00
J-Pharma	01-Mar-2023	000000000 00
KinoPharma	01-Mar-2023	000000000 00
Momotaro Gene	01-Mar-2023	000000000 00
Thermalin	01-Mar-2023	000000000 00
Two Cells	01-Dec-2022	000000000 00
Comera Life Sciences	19-May-2022	Reverse Merger	00000
KORTUC	05-Nov-2021	Later Stage VC	000.00

You’re viewing 10 of 24 exits. Get the full list »

Life Science Venture Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.